HYPE3

Hypera S.A. (HYPE3)

Sector: Farmacêutico e Higiene · Share price: R$ 21.34 (close on Jul 31, 2026) · Dividend yield (12m): 5.18% · 52-week range: R$ 19.88 – 27.79

Company details (CVM registry)

CNPJ (tax ID): 02.932.074/0001-91
CVM code: 21431
Sector: Farmacêutico e Higiene
CVM category: Category A
Headquarters: SÃO PAULO / SP
Investor Relations Officer: Ramon Sanches Frutuoso Silva
Auditor: PRICEWATERHOUSECOOPERS AUDITORES INDEPENDENTES LTDA.
CVM registration: Apr 16, 2008
Status: ACTIVE

Dividends by year

2026: R$ 0.5261 across 2 payment(s)
2025: R$ 1.1581 across 4 payment(s)
2024: R$ 1.1559 across 9 payment(s)
2023: R$ 1.2189 across 4 payment(s)
2022: R$ 1.2194 across 4 payment(s)
2021: R$ 1.2213 across 4 payment(s)
2020: R$ 1.1612 across 4 payment(s)
2019: R$ 1.0591 across 4 payment(s)
2018: R$ 1.8690 across 5 payment(s)
2017: R$ 0.6443 across 2 payment(s)

Recent filings (CVM)

Jul 10, 2026 — Securities traded and held (art. 11, CVM Instruction 358): Securities traded and held (art. 11, CVM Instruction 358)
Jul 10, 2026 — Securities traded and held (art. 11, CVM Instruction 358): Securities traded and held (art. 11, CVM Instruction 358)
Jun 23, 2026 — Notice to Shareholders: Dividendos/Juros sobre Capital Próprio
Jun 23, 2026 — Board/Management Meeting: Distribuição de Dividendos/Juros sobre Capital Próprio
Jun 10, 2026 — Securities traded and held (art. 11, CVM Instruction 358): Securities traded and held (art. 11, CVM Instruction 358)
Jun 10, 2026 — Securities traded and held (art. 11, CVM Instruction 358): Securities traded and held (art. 11, CVM Instruction 358)
May 28, 2026 — Corporate Events Calendar: Corporate Events Calendar
May 13, 2026 — Financial Statements & Data: Demonstrações Financeiras em Padrões Internacionais
May 11, 2026 — Securities traded and held (art. 11, CVM Instruction 358): Securities traded and held (art. 11, CVM Instruction 358)
May 11, 2026 — Notice to the Market: Declaração de Aquisição de Participação Acionária Relevante - Art.12 da Instrução CVM nº358/02
May 11, 2026 — Notice to the Market: Declaração de Alienação de Participação Acionária Relevante - Art.12, §4º, da Instrução CVM nº358/02
May 8, 2026 — Securities traded and held (art. 11, CVM Instruction 358): Securities traded and held (art. 11, CVM Instruction 358)
May 8, 2026 — Securities traded and held (art. 11, CVM Instruction 358): Securities traded and held (art. 11, CVM Instruction 358)
May 8, 2026 — Board/Management Meeting: Apreciação dos resultados do primeiro trimestre de 2026
May 7, 2026 — Plano de Remuneração Baseado em Ações (exceto Plano de Opções): Plano de Remuneração Baseado em Ações (exceto Plano de Opções)
May 7, 2026 — Board/Management Meeting: Apreciação dos resultados do primeiro trimestre de 2026
Apr 30, 2026 — Financial Statements & Data: Relatório Anual do Agente Fiduciário - 12ª Emissão de Debêntures
Apr 30, 2026 — Financial Statements & Data: Relatório Anual do Agente Fiduciário - 11ª Emissão de Debêntures
Apr 30, 2026 — Financial Statements & Data: 9ª Emissão - Relatório Anual do Agente Fiduciário - 2025
Apr 30, 2026 — Financial Statements & Data: 8ª Emissão - Relatório Anual do Agente Fiduciário - 2025

Data content (price, dividends and filings); not investment advice. Sources: B3/Yahoo Finance and CVM (Brazilian SEC).